| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients R Cervera, JC Piette, J Font, MA Khamashta, Y Shoenfeld, MT Camps, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 2653 | 2002 |
| Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ... Medicine 82 (5), 299-308, 2003 | 1847 | 2003 |
| Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD SEBASTIANI, A Gil, P Lavilla, ... Medicine 72 (2), 113-124, 1993 | 1385 | 1993 |
| Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ... Arthritis & Rheumatism 46 (8), 2121-2131, 2002 | 1352 | 2002 |
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 1170* | 2015 |
| The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ... Annals of the rheumatic diseases 69 (01), 61-64, 2010 | 616 | 2010 |
| Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ... Medicine 78 (3), 167-175, 1999 | 603 | 1999 |
| Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ... Arthritis & rheumatism 50 (12), 3934-3940, 2004 | 481 | 2004 |
| Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? A Fioravanti, L Cantarini, GM Guidelli, M Galeazzi Rheumatology international 31, 1-8, 2011 | 319 | 2011 |
| miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis V Fulci, G Scappucci, GD Sebastiani, C Giannitti, D Franceschini, ... Human immunology 71 (2), 206-211, 2010 | 303 | 2010 |
| Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta‐analysis FB Karassa, A Afeltra, A Ambrozic, DM Chang, F De Keyser, A Doria, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 262 | 2006 |
| Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (FOCUS) initiative AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr, AP Brézin, SP Chee, ... Ophthalmology 125 (5), 757-773, 2018 | 257 | 2018 |
| Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled … A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ... Arthritis & rheumatology 71 (4), 599-611, 2019 | 248 | 2019 |
| Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes A Spreafico, F Chellini, B Frediani, G Bernardini, S Niccolini, T Serchi, ... Journal of Cellular Biochemistry 108 (5), 1153-1165, 2009 | 203 | 2009 |
| Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the … F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ... Autoimmunity reviews 12 (2), 225-229, 2012 | 200 | 2012 |
| Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the “Euro-Lupus Project” R Cervera Autoimmunity reviews 5 (3), 180-186, 2006 | 197 | 2006 |
| Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed B Frediani, G Filippou, P Falsetti, S Lorenzini, F Baldi, C Acciai, C Siagkri, ... Annals of the rheumatic diseases 64 (4), 638-640, 2005 | 195 | 2005 |
| Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. L Mancarella, F Bobbio-Pallavicini, F Ceccarelli, PC Falappone, ... The Journal of rheumatology 34 (8), 1670-1673, 2007 | 187 | 2007 |
| HCV infection: pathogenesis, clinical manifestations and therapy A Antonelli, C Ferri, M Galeazzi, C Giannitti, D Manno, G Mieli-Vergani, ... Clinical and Experimental rheumatology 26 (2), S39, 2008 | 178 | 2008 |
| Hyperhomocysteinemia, inflammation and autoimmunity PE Lazzerini, PL Capecchi, E Selvi, S Lorenzini, S Bisogno, M Galeazzi, ... Autoimmunity reviews 6 (7), 503-509, 2007 | 169 | 2007 |
